Cargando…
Fabricating transdermal film formulations of montelukast sodium with improved chemical stability and extended drug release
Montelukast Sodium (MK) is a leukotriene receptor antagonist, an oral drug generally prescribed to control chronic asthma symptoms. This research aims to provide the transdermal delivery of this drug in a controlled release profile as a better mode of drug delivery, specifically for the pediatric an...
Autores principales: | Aashli, Reddy, S. Giridhar, Siva Kumar, B., Prashanthi, K., Murthy, H.C. Ananda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025145/ https://www.ncbi.nlm.nih.gov/pubmed/36950594 http://dx.doi.org/10.1016/j.heliyon.2023.e14469 |
Ejemplares similares
-
Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability
por: Im, Sung Hyun, et al.
Publicado: (2019) -
Bioequivalence of two formulations of montelukast sodium 4 mg oral granules in healthy adults
por: Fey, Constanze, et al.
Publicado: (2014) -
Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry(®) yellow 20A82938 on an industrial scale
por: Zaid, Abdel Naser, et al.
Publicado: (2013) -
Formulation and evalution of montelukast sodium - chitosan based spray dried microspheres for pulmonary drug delivery
por: Panchal, Rushi, et al.
Publicado: (2012) -
In Vivo Predictive Dissolution Testing of Montelukast Sodium Formulations Administered with Drinks and Soft Foods to Infants
por: Martir, J., et al.
Publicado: (2020)